Evidence map›Paper›PMID 41645061›Full record

ArticleBMC genomics2026

IFNγ shapes macrophage inflammatory responses by STAT1 isoform-specific epigenetic and transcriptional mechanisms.

Mojoyinola Joanna Akagha, Grigorios Georgolopoulos, David Martin, Katrin Meissl, Lena Amenitsch, Claus Vogl, Matthias Farlik, Nikolaus Fortelny, Florian Halbritter, Mathias Müller and 2 more

Abstract read
In one paragraph

Article in BMC genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Label-free NbNanoscale horizons · 2026
    Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mojoyinola Joanna AkaghaDepartment of Biological Sciences and Pathobiology, University of Veterinary Medicine Vienna, Veterinärplatz 1, Vienna, 1210, Austria.
Grigorios GeorgolopoulosGenevia Technologies, Hämeenkatu 14 C 33, Tampere, 33100, Finland.
David MartinDepartment of Biological Sciences and Pathobiology, University of Veterinary Medicine Vienna, Veterinärplatz 1, Vienna, 1210, Austria.
Katrin MeisslDepartment of Biological Sciences and Pathobiology, University of Veterinary Medicine Vienna, Veterinärplatz 1, Vienna, 1210, Austria.
Lena AmenitschDepartment of Biological Sciences and Pathobiology, University of Veterinary Medicine Vienna, Veterinärplatz 1, Vienna, 1210, Austria.
Claus VoglDepartment of Biological Sciences and Pathobiology, University of Veterinary Medicine Vienna, Veterinärplatz 1, Vienna, 1210, Austria.
Matthias FarlikDepartment of Dermatology, Medical University of Vienna, Währinger Gürtel 18-20, Vienna, 1090, Austria.
Nikolaus FortelnyDepartment of Biosciences and Medical Biology, Center for Tumor Biology and Immunology, University Salzburg, Hellbrunner Straße 34, Salzburg, 5020, Austria.
Florian HalbritterSt. Anna Children's Cancer Research Institute (CCRI), Zimmermannplatz 10, Vienna, 1090, Austria.
Mathias MüllerDepartment of Biological Sciences and Pathobiology, University of Veterinary Medicine Vienna, Veterinärplatz 1, Vienna, 1210, Austria.
Thomas DeckerMax Perutz Labs (MPL), University of Vienna, Dr.-Bohr-Gasse 9, Vienna, 1030, Austria.
Birgit StroblDepartment of Biological Sciences and Pathobiology, University of Veterinary Medicine Vienna, Veterinärplatz 1, Vienna, 1210, Austria. birgit.strobl@vetmeduni.ac.at.

Funding

Austrian Science Fund P34286-BAustrian Science Fund SFB-F6101, SFB-F6106Austrian Science Fund SFB-F6103
6 · The paper itself

Abstract

backgroundInterferon-γ (IFNγ) is a key cytokine that activates macrophages and is essential for the defence against intracellular pathogens. Beyond its immediate effects, IFNγ also shapes macrophages for subsequent encounters with pathogen-associated molecules by multiple mechanisms, including chromatin remodelling. Here, we employed integrated epigenomic and transcriptomic approaches utilizing primary macrophages from gene-modified mice to explore the role of STAT1 and its naturally occurring isoforms in these processes.

resultsUsing ChIP-seq for histone modifications (H3K27ac and H3K4me1) and RNA-seq, we demonstrate that STAT1 isoforms differentially modulate macrophage responses to lipopolysaccharide (LPS) following IFNγ conditioning. We provide genetic evidence that STAT1 isoforms exhibit distinct capacities to mediated IFNγ-induced changes in H3K27 acetylation at promoter and enhancer regions, thereby shaping transcriptional responses to LPS. We show that the STAT1β isoform, which lacks the C-terminal transactivation domain (TAD), is unable to mediate the repressive effect of IFNγ on transcriptional regulation by LPS but retains significant collaborative activity. Furthermore, we show that IFNγ attenuates the induction of a subset of antiviral genes and represses LPS-induced negative feedback loops, thereby amplifying the inflammatory response to pathogens. These effects are dependent on the presence of the STAT1 C-terminal TAD, highlighting its importance in fine-tuning the balance between inflammatory and antiviral responses.

conclusionsOur findings uncover isoform-specific roles of STAT1 in IFNγ-driven epigenetic regulation and macrophage conditioning, providing new insights into the control of inflammation and innate immunity.

Indexed as

Epigenesis, GeneticInflammationInterferon-gammaMacrophagesSTAT1 Transcription FactorTranscription, GeneticAnimalsGene Expression RegulationHistonesLipopolysaccharidesMiceProtein IsoformsHistonesInterferon-gammaLipopolysaccharidesProtein IsoformsStat1 protein, mouseSTAT1 Transcription FactorH3K27acH3K4me1Interferon- γLipopolysaccharide (LPS)Macrophage conditioningRNA-seq

Identifiers

PMID41645061
PMCPMC12973885

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.